匯控(00005.HK)明起至10月26日回購最多20億美元股份
匯豐控股(00005.HK)進一步展開最多達20億美元的股份回購。所回購之普通股將被註銷。
匯豐與Merrill Lynch已訂立多項不可撤回之非全權委託回購協議,讓Merrill Lynch可於8月3日至不遲於10 月26日期間購買總值最多為20億美元普通股,並同時向匯豐出售有關股份。
購買普通股行動將於倫敦證券交易所、Cboe Europe Limited(透過BXE及CXE交易委託賬本)或Turquoise或香港聯交所進行。
是項回購最多可購買17.39億股普通股,即扣除2023年授權獲授出至今公司已回購股份數目後,根據該授權可回購普通股數目。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.